Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
PLoS One ; 9(5): e96445, 2014.
Article de Anglais | MEDLINE | ID: mdl-24831610

RÉSUMÉ

The use of siRNAs to knock down gene expression can potentially be an approach to treat various diseases. To avoid siRNA toxicity the less transcriptionally active H1 pol III promoter, rather than the U6 promoter, was proposed for siRNA expression. To identify highly efficacious siRNA sequences, extensive screening is required, since current computer programs may not render ideal results. Here, we used CCR5 gene silencing as a model to investigate a rapid and efficient screening approach. We constructed a chimeric luciferase-CCR5 gene for high-throughput screening of siRNA libraries. After screening approximately 900 shRNA clones, 12 siRNA sequences were identified. Sequence analysis demonstrated that most (11 of the 12 sequences) of these siRNAs did not match those identified by available siRNA prediction algorithms. Significant inhibition of CCR5 in a T-lymphocyte cell line and primary T cells by these identified siRNAs was confirmed using the siRNA lentiviral vectors to infect these cells. The inhibition of CCR5 expression significantly protected cells from R5 HIV-1JRCSF infection. These results indicated that the high-throughput screening method allows efficient identification of siRNA sequences to inhibit the target genes at low levels of expression.


Sujet(s)
Tests de criblage à haut débit/méthodes , Luciferases/génétique , Petit ARN interférent/métabolisme , Algorithmes , Lignée cellulaire , ADN/composition chimique , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes , Banque de gènes , Vecteurs génétiques , Cellules HEK293 , Humains , Agranulocytes/cytologie , Régions promotrices (génétique) , Interférence par ARN , Récepteurs CCR5/génétique , Lymphocytes T/cytologie , Transfection
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...